Outlast
You're already doing retinol. This is the internal version.
This is the category for people who've gone deep enough on PubMed to know aging is a series of cellular failures — and that some of those failures might be fixable. Mitochondrial peptides, telomere maintenance, NAD+ restoration. The science is real, the mouse data is exciting, and the human clinical evidence is still catching up. Not where you start if you've never prepped a vial, but deeply interesting if you have.
Top Peptides for Outlast
- MOTS-c (relevance: 85%) — Mitochondrial-derived peptide that mimics exercise at a cellular level and improves insulin sensitivity. Some of the most interesting longevity research happening right now, full stop.
- SS-31 (Elamipretide) (relevance: 82%) — Goes straight to the inner mitochondrial membrane and fights oxidative stress at the source. Clinical trials running for heart failure and kidney disease — this one's being taken seriously.
- Epithalon (relevance: 78%) — Activates telomerase to maintain telomere length. Based on decades of Russian research by Khavinson. Big claims, limited Western peer review, but a devoted following that won't shut up about it.
- NAD+ (relevance: 75%) — Not technically a peptide but always grouped with them. NAD+ declines with age; supplementation tries to restore cellular energy production. IV is the most bioavailable route — and the most expensive.
Common Questions
- Which longevity peptide has the most evidence?
- Can I take MOTS-c instead of exercising?
- How do I know if epithalon is actually doing anything?
- Is NAD+ worth the cost of IV infusions?
- What's the difference between SS-31 and just taking CoQ10?
Related Comparisons
- MOTS-c vs SS-31 — Two mitochondrial peptides, two completely different playbooks. One signals, the other shields.
← Browse all peptides
These statements have not been evaluated by the FDA. This content is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any protocol.
vialprep research · Sources: PubMed, FDA, peer-reviewed trials · How we verify